rs2271101
Variant names: 
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000027.4(AGA):c.507+180T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.448 in 151,966 control chromosomes in the GnomAD database, including 15,461 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
 Genomes: 𝑓 0.45   (  15461   hom.,  cov: 32) 
Consequence
 AGA
NM_000027.4 intron
NM_000027.4 intron
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -0.891  
Publications
18 publications found 
Genes affected
 AGA  (HGNC:318):  (aspartylglucosaminidase) This gene encodes a member of the N-terminal nucleophile (Ntn) hydrolase family of proteins. The encoded preproprotein is proteolytically processed to generate alpha and beta chains that comprise the mature enzyme. This enzyme is involved in the catabolism of N-linked oligosaccharides of glycoproteins. It cleaves asparagine from N-acetylglucosamines as one of the final steps in the lysosomal breakdown of glycoproteins. Mutations in this gene are associated with the lysosomal storage disease aspartylglycosaminuria that results in progressive neurodegeneration. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is subject to proteolytic processing. [provided by RefSeq, Nov 2015] 
AGA Gene-Disease associations (from GenCC):
- aspartylglucosaminuriaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, G2P, Orphanet, Myriad Women’s Health, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91). 
BP6
Variant 4-177438565-A-G is Benign according to our data. Variant chr4-177438565-A-G is described in ClinVar as Benign. ClinVar VariationId is 1254787.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.465  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| AGA | NM_000027.4 | c.507+180T>C | intron_variant | Intron 4 of 8 | ENST00000264595.7 | NP_000018.2 | ||
| AGA | NM_001171988.2 | c.507+180T>C | intron_variant | Intron 4 of 8 | NP_001165459.1 | |||
| AGA | NR_033655.2 | n.569+180T>C | intron_variant | Intron 4 of 7 | ||||
| AGA | XM_047449722.1 | c.507+180T>C | intron_variant | Intron 4 of 6 | XP_047305678.1 | 
Ensembl
Frequencies
GnomAD3 genomes  0.448  AC: 68058AN: 151848Hom.:  15429  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
68058
AN: 
151848
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome  0.448  AC: 68136AN: 151966Hom.:  15461  Cov.: 32 AF XY:  0.444  AC XY: 32958AN XY: 74246 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
68136
AN: 
151966
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
32958
AN XY: 
74246
show subpopulations 
African (AFR) 
 AF: 
AC: 
18453
AN: 
41424
American (AMR) 
 AF: 
AC: 
6825
AN: 
15266
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
1392
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
1536
AN: 
5162
South Asian (SAS) 
 AF: 
AC: 
1523
AN: 
4812
European-Finnish (FIN) 
 AF: 
AC: 
5126
AN: 
10542
Middle Eastern (MID) 
 AF: 
AC: 
119
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
31929
AN: 
67972
Other (OTH) 
 AF: 
AC: 
885
AN: 
2114
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.503 
Heterozygous variant carriers
 0 
 1941 
 3882 
 5822 
 7763 
 9704 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 634 
 1268 
 1902 
 2536 
 3170 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
1157
AN: 
3478
ClinVar
Significance: Benign 
Submissions summary: Benign:2 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not provided    Benign:2 
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 28, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.